Etanercept (TNF receptor fusion protein, enbrel®) is effective and well tolerated in active refractory Crohn's disease: Results of a single center pilot trial

✍ Scribed by G. D'Haens; K. Geboes; M. Noman; L. Lemmens; P. Rutgeerts

• Book ID: 119629633
• Publisher: Elsevier Science
• Year: 2000
• Tongue: English
• Weight: 158 KB
• Volume: 32
• Category: Article
• ISSN: 1590-8658
• DOI: 10.1016/s1590-8658(00)80213-3